National Centre For Pharmacoeconomics

The HSE seems set to reject a “ground-breaking” but highly expensive drug for patients with cystic fibrosis in the public health system. The HSE said(...)

The HSE is negotiating a price for the drug Orkambi for use in treatment of cystic fibrosis (CF) patients, Taoiseach Enda Kenny has said. He said me(...)

A “wonder drug” used to treat adult cystic fibrosis patients has been rejected for use in a group of child patients after a study found it would cost (...)

A cancer drug considered too expensive for the Irish health service has been found to significantly extend survival rates for patients with kidney can(...)

Cystic fibrosis (CF) campaigns have launched a punchy social media campaign to persuade the Government to approve Orkambi, a drug that costs €160,000 (...)

How do you put a price on a life? In a week when melanoma cancer patients were told the State would reimburse the costs of a new immunotherapy agent(...)

O! What a beautiful morning! A little less beautiful today if you are a member of the new Government, though. There you are, settling in to your new(...)

Cystic fibrosis patients have expressed disappointment after a “game-changing” drug was rejected on cost effectiveness grounds. Orkambi, which greatl(...)

The HSE is expected to make a new cancer drug available free to patients with melanoma. Pembrolizumab should be included in the State drugs scheme fo(...)

A new €160,000 drug that cystic fibrosis (CF) campaigners have described as a “game-changer” has been rejected for Irish patients on cost effectivenes(...)